Organization | Association Asthma, Bulgaria

Association Asthma, Bulgaria Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Sofia Bulgaria (1998)

Organization Overview

First Clinical Trial

2011

NCT01250652

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

Prof. Todor Popov

Active Ingredients

Drugs in Phase 4 Trials (11)

azelastine (astelin) (1 trial)

bilastine (1 trial)

hydroxyzine (vistaril) (1 trial)

hypromelloses (2 trials)

lactose (1 trial)

levocetirizine (xyzal) (1 trial)

mometasone (elocon) (1 trial)

montelukast (singulair) (1 trial)

prednisone (meticorten) (1 trial)

timothy grass pollen allergen extract (Grastek) (1 trial)

xylometazoline (1 trial)

Drugs in Phase 2 Trials (1)

oxymetazoline (ocuclear) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cough (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Seasonal (Phase 4)

Urticaria (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 12